Search research articles
Contact Us
Filters
Showing results (331-340 of 427) with videos related to
Page
of 43
Sort By:
Clinical Breast Cancer
|
September 23, 2022
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Vanessa Wong, Richard de Boer, Sally Baron-Hay, et al.
Cell Death & Disease
|
September 11, 2020
Defining the susceptibility of colorectal cancers to BH3-mimetic compounds
Ming-Jie Luo, Michelle Palmieri, Chris D Riffkin, et al.
Clinical Colorectal Cancer
|
September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status
Avraham Travers, Azim Jalali, Stephen Begbie, et al.
Clinical Genitourinary Cancer
|
May 4, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study
Colin Williams, Andrisha-Jade Inderjeeth, Wei Hong, et al.
Internal Medicine Journal
|
October 28, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia
Natasha Yap, Vanessa Wong, Catherine Morton, et al.
Journal of the National Cancer Institute
|
August 12, 2009
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial
Nicole Mittmann, Heather-Jane Au, Dongsheng Tu, et al.
JCO Oncology Practice
|
June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations
Ciara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study
Belinda Lee, Hui-Li Wong, Mark Tacey, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 29, 2026
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series
Kar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, et al.
Current Problems in Cancer
|
August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer
Thiru Prasanna, Rachel Wong, Timothy Price, et al.
Page
of 43
Search research articles
Search
Showing results (331-340 of 427) with videos related to
Sort By:
Page
of 43
Clinical Breast Cancer
|
September 23, 2022
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Vanessa Wong, Richard de Boer, Sally Baron-Hay, et al.
Cell Death & Disease
|
September 11, 2020
Defining the susceptibility of colorectal cancers to BH3-mimetic compounds
Ming-Jie Luo, Michelle Palmieri, Chris D Riffkin, et al.
Clinical Colorectal Cancer
|
September 13, 2020
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status
Avraham Travers, Azim Jalali, Stephen Begbie, et al.
Clinical Genitourinary Cancer
|
May 4, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study
Colin Williams, Andrisha-Jade Inderjeeth, Wei Hong, et al.
Internal Medicine Journal
|
October 28, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia
Natasha Yap, Vanessa Wong, Catherine Morton, et al.
Journal of the National Cancer Institute
|
August 12, 2009
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial
Nicole Mittmann, Heather-Jane Au, Dongsheng Tu, et al.
JCO Oncology Practice
|
June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations
Ciara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study
Belinda Lee, Hui-Li Wong, Mark Tacey, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 29, 2026
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series
Kar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, et al.
Current Problems in Cancer
|
August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer
Thiru Prasanna, Rachel Wong, Timothy Price, et al.
Page
of 43